The University of Nottingham unveils the world's first mobile quantum brain scanner, designed to monitor the impact of blast exposure on the brain in real time.
The NIH has established the Standardized Organoid Modeling Center, aiming to develop reproducible, human-based models using AI and robotics, reducing reliance on animal testing.
A new gene therapy called AMT-130 has shown promising results in slowing the progression of Huntington’s disease, according to the latest results from a global clinical trial.
Lorna Rothery spoke with Victoria Hedley, co-lead of the Rare Disease Research UK Hub, about initiatives aimed at advancing the agenda for rare diseases, as well as the importance of facilitating cross-border collaboration to promote best practices and advance critical research.
A new report starkly reveals the severe and wide-ranging damage that fossil fuels inflict on human health, from the earliest stages of life to old age.
Although age is a risk factor, there are other modifiable factors that can influence dementia risk and disease progression. Angela Bradshaw, the Director for Research at Alzheimer Europe, emphasises the need for more comprehensive interventions across multiple areas to support dementia prevention
UKRI-funded researchers are using AI and Xenon gas imaging to make MRI scans faster, cheaper, and more accurate, improving lung disease diagnosis across the NHS.
UCL researchers have developed an ultrasound helmet that enables deep brain stimulation without surgery, offering hope for Parkinson's and other neurological disorders.
Researchers have developed an AI stethoscope that discovers heart conditions in 15 seconds, giving NHS GPs a quick and simple tool to spot problems earlier.
Afon Technology is pioneering advancements in diabetes care with its innovative device, Glucowear™, which is being developed as the world’s first non-invasive, real-time, continuous blood glucose monitor.
A Harvard study finds that following a Mediterranean diet can lower dementia risk for those with high genetic susceptibility, including APOE4 carriers.
